Table 6.

Multiple Endocrine Neoplasia Type 4: Recommended Surveillance

System/ConcernEvaluationFrequency 1
PHPT
  • Serum calcium
  • PTH & vitamin D measurement may also be considered to ensure sufficiency.
Biennially (every 2 yrs) starting at age 25 yrs
Pituitary adenoma Serum IGF-1 & prolactinEvery 3-5 yrs or as symptoms indicate, starting at age 25 yrs
Pituitary MRIImaging every 5 yrs starting at age 25 yrs
If clinical concern for Cushing disease, perform 24-hr urine free cortisol, late night salivary cortisol, &/or 1 mg overnight dexamethasone suppression test.
Neuroendocrine tumors & carcinoids Serum gastrinBiannually starting at age 25 yrs
Abdominal MRI (or CT)Imaging every 5 yrs starting at age 25 yrs, increasing to every 2.5 yrs at age 40 yrs

IGF-1 = insulin-like growth factor 1; PHPT = primary hyperparathyroidism; PTH = parathyroid hormone

1.

Abnormal findings would indicate the need for more frequent follow up (current multiple endocrine neoplasia type 1 treatment guidelines can be used as a guide).

From: Multiple Endocrine Neoplasia Type 4

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.